Tonix Pharmaceuticals Holding Corp. (TNXP)
USD 0.36
(9.25%)
USD 0.36
(9.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 7.76 Million | - | - | - | - | - |
| Cost of Revenue | 4.74 Million | 112.09 Million | 92.31 Million | 50.51 Million | 28.82 Million | 26.32 Million |
| Gross Profit | 3.02 Million | -112.09 Million | -92.31 Million | -50.51 Million | -28.82 Million | -26.32 Million |
| Operating Expenses | 121.4 Million | 112.09 Million | 92.31 Million | 50.51 Million | 28.82 Million | 26.32 Million |
| Selling, General and Administrative Expenses | 34.75 Million | 30.21 Million | 23.47 Million | 14.35 Million | 10.63 Million | 8.76 Million |
| Research and Development Expenses | 86.65 Million | 81.87 Million | 68.83 Million | 36.15 Million | 18.19 Million | 17.55 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 126.14 Million | 112.09 Million | 92.31 Million | 50.51 Million | 28.82 Million | 26.32 Million |
| Operating Income | -118.38 Million | -112.09 Million | -92.31 Million | -50.51 Million | -28.82 Million | -26.32 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | 4.78 Million | -75 Thousand | -75 Thousand | -236 Thousand | 233 Thousand |
| Earnings before Tax | -116.65 Million | -110.21 Million | -92.28 Million | -50.46 Million | -28.61 Million | -26.08 Million |
| Net Income | -116.65 Million | -116.87 Million | -92.28 Million | -52.17 Million | -31.09 Million | -29.35 Million |
| Earnings Per Share Basic | -219.09 | -640.26 | -1620.86 | -3530.04 | - | - |
| Earnings Per Share Diluted | -219.09 | -640.26 | -1620.86 | -3530.04 | - | - |
| Weighted Average Shares Outstanding | 532.47 Thousand | 182.54 Thousand | 56.93 Thousand | 14.78 Thousand | - | - |
| Weighted Average Shares Outstanding (Diluted) | 532.47 Thousand | 182.54 Thousand | 56.93 Thousand | 14.78 Thousand | - | - |
| Gross Margin | 0.39 | - | - | - | - | - |
| EBIT Margin | -14.69 | - | - | - | - | - |
| Profit Margin | -15.02 | - | - | - | - | - |
| EBITDA | -114.08 Million | -110.83 Million | -92.26 Million | -50.48 Million | -28.8 Million | -26.26 Million |
| Earnings Before Tax Margin | -15.24 | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.2 Million | 2.48 Million | 3.77 Million | 7.76 Million | 3.98 Million | - |
| Cost of Revenue | 4.57 Million | 1.66 Million | 3.85 Million | 9.03 Million | 2.37 Million | 29 Million |
| Gross Profit | -2.36 Million | 822 Thousand | -79 Thousand | -1.26 Million | 1.61 Million | -29 Million |
| Operating Expenses | 15.99 Million | 22.17 Million | 27.25 Million | 117.11 Million | 29.76 Million | 29 Million |
| Selling, General and Administrative Expenses | 6.29 Million | 9.31 Million | 10.13 Million | - | 8.71 Million | 7.02 Million |
| Research and Development Expenses | 9.69 Million | 12.86 Million | 17.12 Million | - | 21.05 Million | 21.97 Million |
| Other Expenses | -605 Thousand | -593 Thousand | - | 1.72 Million | - | 646 Thousand |
| Cost and Expenses | 20.56 Million | 23.83 Million | 31.1 Million | 126.14 Million | 32.13 Million | 29 Million |
| Operating Income | -18.35 Million | -21.35 Million | -27.32 Million | -118.38 Million | -28.14 Million | -29 Million |
| Interest Expense | - | - | 1.79 Million | - | - | - |
| Income Tax Expense | - | -1.21 Million | - | -1.00 | -1.21 Million | 29 Million |
| Earnings before Tax | -78.77 Million | -14.93 Million | -27.32 Million | -116.65 Million | -27.97 Million | -28.35 Million |
| Net Income | -78.77 Million | -14.93 Million | -27.32 Million | -116.65 Million | -27.97 Million | -28.35 Million |
| Earnings Per Share Basic | -19.28 | -5.91 | -27.53 | - | -58.40 | -85.71 |
| Earnings Per Share Diluted | -19.28 | -5.91 | -27.53 | - | -58.40 | -85.71 |
| Weighted Average Shares Outstanding | 4.08 Million | 2.52 Million | 992.39 Thousand | 532.47 Thousand | 478.98 Thousand | 330.84 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 4.08 Million | 2.52 Million | 992.39 Thousand | 532.47 Thousand | 478.98 Thousand | 330.84 Thousand |
| Gross Margin | -1.07 | 0.33 | -0.02 | -0.16 | 0.40 | - |
| EBIT Margin | -7.77 | -8.60 | -6.84 | - | -7.06 | - |
| Profit Margin | -35.68 | -6.02 | -7.23 | -15.02 | -7.01 | - |
| EBITDA | -17.15 Million | -21.35 Million | -25.83 Million | - | -28.14 Million | -28.08 Million |
| Earnings Before Tax Margin | -8.31 | -8.60 | -7.23 | -15.24 | -7.06 | - |
GNENF
AGDXF
PEB
BANKBARODA
DCO
2338